|
|
||||||||
Editorials |
This editorial summarizes the mechanisms of mupirocin resistance and the conditions that promote its development. While there is increasing evidence that high-level mupirocin resistance is developing during systematic use of mupirocin as prophylaxis against Staphylococcus aureus, the appearance of resistance does not preclude the beneficial effect of regular prophylaxis. Vigilance has to be exercised to notice larger-scale resistance that may require limiting the use of mupirocin.
This article has been cited by other articles:
![]() |
D. W. Johnson, C. van Eps, D. W. Mudge, K. J. Wiggins, K. Armstrong, C. M. Hawley, S. B. Campbell, N. M. Isbel, G. R. Nimmo, and H. Gibbs Randomized, Controlled Trial of Topical Exit-Site Application of Honey (Medihoney) versus Mupirocin for the Prevention of Catheter-Associated Infections in Hemodialysis Patients J. Am. Soc. Nephrol., May 1, 2005; 16(5): 1456 - 1462. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Lobbedez, M. Gardam, H. Dedier, D. Burdzy, M. Chu, S. Izatt, J. M. Bargman, S. V. Jassal, S. Vas, J. Brunton, et al. Routine use of mupirocin at the peritoneal catheter exit site and mupirocin resistance: still low after 7 years Nephrol. Dial. Transplant., December 1, 2004; 19(12): 3140 - 3143. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Zhang, J. Sparling, B. L. Chow, S. Elsayed, Z. Hussain, D. L. Church, D. B. Gregson, T. Louie, and J. M. Conly New Quadriplex PCR Assay for Detection of Methicillin and Mupirocin Resistance and Simultaneous Discrimination of Staphylococcus aureus from Coagulase-Negative Staphylococci J. Clin. Microbiol., November 1, 2004; 42(11): 4947 - 4955. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |